Sequential combined treatment with intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation

Eye

Volumn 24, Issue 8, 2010, Pages 1344-1351

  Viola, F ^a   Mapelli, C ^a   Villani, E ^a   Tresca Carducci, F ^a   Vezzola, D ^a   Ratiglia, R ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

age related macular degeneration; bevacizumab (Avastin); fluorescein angiography; ICG angiography; PDT; RAP

Indexed keywords

BEVACIZUMAB; INDOCYANINE GREEN; VERTEPORFIN;

ABSENCE OF SIDE EFFECTS; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG SAFETY; EYE EXAMINATION; FEMALE; HUMAN; MALE; PHOTODYNAMIC THERAPY; RETINA ANGIOGRAPHY; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINAL ANGIOMATOUS PROLIFERATION; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 77955627363     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2010.33     Document Type: Article

References (27)

1. Viola F, Massacesi A, Orzalesi N, Ratiglia R, Staurenghi G. Retinal angiomatous proliferation: natural history and progression of visual loss. Retina 2009; 29: 732-739.
2. Yannuzzi LA, Negrao S, Iida T, Carvalho C, Rodriguez-Coleman H, Slakter J et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001; 21: 416-434.
3. Gass JD, Agarwal A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen. Retina 2003; 23: 741-751.
4. Freund KB, Ho IV, Barbazetto IA, Koizumi H, Laud K, Ferrara D et al. Type 3 neovascularization: the expanded spectrum of retinal angiomatous proliferation. Retina 2008; 28: 201-211.
5. Johnson TM, Glaser BM. Focal laser ablation of retinal angiomatous proliferation. Retina 2006; 26: 765-772.
6. Kuroiwa S, Arai J, Gaun S, Iida T, Yoshimura N. Rapidly progressive scar formation after transpupillary thermotherapy in retinal angiomatous proliferation. Retina 2003; 23: 417-420.
7. Klais CM, Eandi CM, Ober MD, Sorenson JA, Sadeghi SN, Freund KB et al. Anecortave acetate treatment for retinal angiomatous proliferation: a pilot study. Retina 2006; 26: 773-779.
8. Nakata M, Yuzawa M, Kawamura A, Shimada H. Combining surgical ablation of retinal inflow and outflow vessels with photodynamic therapy for retinal angiomatous proliferation. Am J Ophthalmol 2006; 141: 968-970.
9. Sakimoto S, Gomi F, Sakaguchi H, Tano Y. Recurrent retinal angiomatous proliferation after surgical ablation. Am J Ophthalmol 2005; 139: 917-918.
10. Boscia F, Furino C, Sborgia L, Reibaldi M, Sborgia C. Photodynamic therapy for retinal angiomatous proliferations and pigment epithelium detachment. Am J Ophthalmol 2004; 138: 1077-1079.
11. Nicolo M, Ghiglione D, Lai S, Calabria G. Retinal angiomatous proliferation treated by intravitreal triamcinolone and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1336-1338.
12. Freund KB, Klais CM, Eandi CM, Ober MD, Goldberg DE, Sorenson JA et al. Sequenced combined intravitreal triamcinolone and indocyanine green angiography-guided photodynamic therapy for retinal angiomatous proliferation. Arch Ophthalmol 2006; 124: 487-492.
13. Meyerle CB, Freund KB, Iturralde D, Spaide RF, Sorenson JA, Slakter JS et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007; 27: 451-457.
14. Ghazi NG, Knape RM, Kirk TQ, Tiedeman JS, Conway BP. Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation. Retina 2008; 28: 689-695.
15. Joeres S, Heussen FM, Treziak T, Bopp S, Joussen AM. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007; 245: 1597-1602.
16. Gharbiya M, Allievi F, Recupero V, Martini D, Mazzeo L, Gabrieli CB. Intravitreal bevacizumab as primary treatment for retinal angiomatous proliferation: twelve-month results. Retina 2009; 29: 740-749.
17. Ladewig MS, Karl SE, Hamelmann V, Helb HM, Scholl HP, Holz FG et al. Combined intravitreal bevacizumab and photodynamic therapy for neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2008; 246: 17-25.
18. Saito M, Shiragami C, Shiraga F, Nagayama D, Iida T. Combined intravitreal bevacizumab and photodynamic therapy for retinal angiomatous proliferation. Am J Ophathalmol 2008; 146: 935-941.
19. Lo Giudice G, Gismondi M, De Belvis V, Cian R, Tavolato M, Galan A. Single-session photodynamic therapy combined with intravitreal bevacizumab for retinal angiomatous proliferation. Retina 2009; 29: 949-955.
20. Vujosevic S, Midena E, Pilotto E, Radin PP, Chiesa L, Cavarzeran F. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings. Invest Ophthalmol Vis Sci 2006; 47: 3044-3051.
21. Rouvas AA, Papakostas TD, Ladas ID, Vergados I. Enlargement of the hypofluorescent post photodynamic therapy treatment spot after a combination of photodynamic therapy with an intravitreal injection of bevacizumab for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2008; 246: 315-318.
22. Sutter FK, Kurz-Levin MM, Fleischhauer J, Bösch MM, Barthelmes D, Helbig H. Macular atrophy after combined intravitreal triamcinolone acetonide (IVTA) and photodynamic therapy (PDT) for retinal angiomatous proliferation (RAP). Klin Monatsbl Augenheilkd 2006; 223: 376-378.
23. Yu SY, Damico FM, Viola F, DAmico DJ, Young LH. Retinal toxicity of intravitreal triamcinolone acetonide: a morphological study. Retina 2006; 26: 531-536.
24. Antoszyk AN, Tuomi L, Chung CY, Singh A, FOCUS Study Group. Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results. Am J Ophthalmol 2008; 145: 862-874.
25. Fung AE, Lalwani GA, Rosenfeld PJ, Dubovy SR, Michels S, Feuer WJ et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007; 143: 566-583.
26. Gupta BM, Jyothi S, Sivaprasad S. Current treatment options for retinal angiomatous proliferans (RAP). Br J Ophthalmol published online November 5, 2009. [Epub ahead of print]
27. Rich RM, Rosenfeld PJ. Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular agerelated macular degeneration. Retina 2006; 26: 495-511.